Acción VICP VICAPSYS LIFE SCIENCES, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Vicapsys Life Sciences, Inc.

Acciones

VICP

US92560A1060

Diferido OTC Markets
Otros sitios de cotización
 16:29:14 10/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,444 USD 0,00 % Gráfico intradía de Vicapsys Life Sciences, Inc. 0,00 % -83,80 %
2023 Vicapsys Life Sciences, Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2023 CI
2023 Vicapsys Life Sciences, Inc. informa de los resultados del segundo trimestre y de los seis meses finalizados el 30 de junio de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Vicapsys Life Sciences, Inc. announced that it has received $0.3036 million in funding
Vicapsys Life Sciences, Inc. announced that it expects to receive $0.3036 million in funding
Vicapsys Life Sciences : Change in Certifying Accountants - Form 8-K
VICAPSYS LIFE SCIENCES, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Vicapsys Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
NOTE 2 - GOING CONCERN AND MANAGEMENT'S PLANS
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
Vicapsys Life Sciences, Inc. Announces Board Changes
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Vicapsys Life Sciences, Inc. Appoints Federico Pier as Chief Executive Officer
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción VICP
  4. Noticias Vicapsys Life Sciences, Inc.
  5. Otros idiomas
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA